MRD Testing Practices in Colorectal Cancer

Opinion
Video

GI medical oncologists discuss MRD testing practices in colorectal cancer and provide insights on challenges associated with testing.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
Related Content
Investigators will submit detailed results from the phase 3 STELLAR-303 trial for presentation at a future medical conference.

Zanzalintinib Combo Improves Survival vs Regorafenib in Metastatic CRC

Russ Conroy
June 23rd 2025
Article

Investigators will submit detailed results from the phase 3 STELLAR-303 trial for presentation at a future medical conference.

The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.

Sotorasib Combo Approval May Address Novel Therapy Need in KRAS G12C+ CRC

Marwan G. Fakih, MD
February 24th 2025
Podcast

The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.

Biweekly TAS-102 Reduces Toxicity, Maintains Survival in Metastatic CRC

Biweekly TAS-102 Reduces Toxicity, Maintains Survival in Metastatic CRC

Tim Cortese
June 17th 2025
Article

A retrospective analysis shows that trifluridine/tipiracil with or without bevacizumab given biweekly was favorable in those with colorectal cancer.

Oncology pharmacist Jagoda Misniakiewicz, PharmD, discusses the potential efficacy and safety profile of fruquintinib in patients with metastatic CRC.

Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval

Jagoda Misniakiewicz, PharmD
June 10th 2024
Podcast

Oncology pharmacist Jagoda Misniakiewicz, PharmD, discusses the potential efficacy and safety profile of fruquintinib in patients with metastatic CRC.

Counseling received prior to colorectal surgery using 3-dimensional–printed anatomic models reduced mean anxiety scores vs conventional counseling.

Preoperative Counseling Increases Shared Decision-Making in CRC Surgery

Roman Fabbricatore
June 11th 2025
Article

Counseling received prior to colorectal surgery using 3-dimensional–printed anatomic models reduced mean anxiety scores vs conventional counseling.

Novel Therapy Yields Anti-Tumor Activity in KRAS G12C–Mutated CRC

Novel Therapy Yields Anti-Tumor Activity in KRAS G12C–Mutated CRC

Jason M. Broderick
May 31st 2025
Article

As a single agent or in combination, MK-1084 showed promising efficacy and safety results for patients with KRAS G12C–mutated CRC.